Qube FinTech & AI MENA licensed in the Dubai International Financial Centre becomes the company’s regional headquarters to focus on the GCC and North Africa
QubeHealth-Pay has announced its expansion into the Middle East and North Africa (MENA) region with the launch of Qube FinTech & AI MENA Limited, a newly licensed entity operating out of the Dubai International Financial Centre (DIFC), home to global fintech firms such as Stripe and Wise and financial institutions including BlackRock, Goldman Sachs and Nomura..
The DIFC entity becomes Qube’s regional headquarters for the Gulf Cooperation Council (GCC) and North Africa — the company’s first market outside India.
Qube MENA is structured differently from QubePay, the consumer payments and cashback platform Qube operates in India. In the DIFC, Qube is built to serve insurers, employers, hospital networks, pharmaceutical companies and other enterprise participants across the region, licensing its purpose-built technology to solve financial problems within the healthcare sector.
Its capabilities include digital healthcare expense processing, claims facilitation and documentation, rule-based bill adjudication support, reconciliation infrastructure, and aggregated, consent-driven healthcare data and insights for insurers, employers and healthcare brands.
The expansion responds to a widening healthcare affordability gap across the region. Healthcare costs are rising an estimated 8–12% annually across MENA — outpacing wage growth and, in many markets, government healthcare spending.
Even in relatively well-insured markets such as the UAE, large categories of care including IVF and fertility treatment, dental implants, cosmetic and elective procedures, and wellness programmes remain entirely self-funded.
Out-of-pocket healthcare spending is markedly higher elsewhere in the region, particularly across parts of North and East Africa, where insurance penetration remains limited, and insurance companies are keen to solve various problems related to healthcare payments – a core mission of QubeHealth-Pay.
Qube’s initial regional focus spans four markets — the UAE, Egypt, Kenya and Nigeria — with Dubai serving as the operating and regulatory base. Each market will be entered through an approach suited to its own regulatory and insurance landscape, combining partnerships with local insurers, healthcare providers and financial institutions with selective technology-licensing arrangements.
The company plans a phased rollout: beginning with regulatory engagement and partnership-building, followed by pilot deployments, and broader enterprise onboarding thereafter.
Qube’s India platform — live across more than 300 corporates and reaching over 300,000 employee families — is the operating and product base being localised for MENA’s healthcare systems, insurance structures and regulatory frameworks.
Chris George, Co-Founder & Group CEO, said, “The out-of-pocket healthcare problem we’ve spent years solving in India isn’t unique to India — it shows up across the Middle East and Africa too, just in different forms. In the UAE, it’s the elective and non-insurable care that falls entirely outside insurance. In markets like Egypt, Kenya and Nigeria, it’s the everyday cost of pharmacy, diagnostics and outpatient care.
“Setting up in the DIFC gives us a credible, regulated base to build the technology and data infrastructure insurers, employers and healthcare providers across the region need to manage this — the same problem, adapted to how healthcare is actually paid for and insured here,” added George.
Upcoming E-conference
Other Related stories
MBU hosts national conference on integrating AYUSH with community medicine
<img src="https://www.indianpharmapost.com/public/thumbs/news/2026/09/21802/IHW_195_291.jpeg” alt=”” loading=”lazy”>
Healthcare leaders call for a national patient charter
Marengo Asia Hospitals highlights shift towards neuroplasticity-driven stroke rehabilitation
Interviews
Targeting Dual PIC/S and EU GMP accreditation to boost global standards: Chirag Doshi, Director, Yesh Medicare
We are setting up a plant in Uganda:Krushank Shah, Business Development Manager, S Kant Healthcare
Exploring to expand into biological medicines through lab partnerships: Nikkhil K. Masurkar, CEO, Entod Pharmaceuticals
Appointments
HAB Pharma appoints Pankaj Agarwal as CFO
Amitabh Dube appointed OPPI President
Neurizon appoints Dr. Chris Bremer as CEO
Startup
BIRAC showcases India’s biotech and assistive tech start-ups at Bharatiya Vyapar Mahotsav 2026
Ayati Devices raises Rs. 15 Crore in pre-series A round led by Inflexor Ventures
CARPL.ai raises US$ 10 million in Series A led by IFC to scale global clinical AI platform
Digitization
Sanofi signs three-year partnership with Tricog to scale AI-powered cardiac diagnostics
Medibyt secures FDA clearance for CPETWise digital health platform
IIT Madras, CMC Vellore develop AI tools for early kidney disease detection
Upcoming Events
Latest Stories
Revvity to acquire human cell design in push to advance metabolic disease drug discovery
AstraZeneca’s Tozorakimab cuts COPD exacerbations by up to 34% in broad Phase III population
Brenntag and Indovinya strike exclusive European distribution deal for pharmaceutical excipients
IOL Chemicals Unveils Rs 495-crore expansion push across APIs, CDMO & specialty chemicals
Glenmark launches RYALTRIS to treat allergic rhinitis in Brazil
White Papers
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
Opinion
AI will redefine the future of precision medicine: Kalyan Kolachala, Managing Director, SymphonyAI Group India
Transforming Indian healthcare innovation, investment, and patient-centric care: Nitin Thakur, Business Head, Meril Lifesciences
Interviews
Targeting Dual PIC/S and EU GMP accreditation to boost global standards: Chirag Doshi, Director, Yesh Medicare
We are setting up a plant in Uganda:Krushank Shah, Business Development Manager, S Kant Healthcare
Exploring to expand into biological medicines through lab partnerships: Nikkhil K. Masurkar, CEO, Entod Pharmaceuticals
Packaging
Amcor upgrades Illinois facility with advanced automation to bolster healthcare packaging safety
Amcor joins forces with Kelpi to push bio-based barrier coatings for fiber packaging
